Evopoint Biosciences Inc.
Clinical trials sponsored by Evopoint Biosciences Inc., explained in plain language.
-
New antibiotic cocktail shows promise against tough lung infections
Disease control CompletedThis study tested a new antibiotic combination (IMI-XNW4107) against an existing one (IMI/REL) in 450 adults with pneumonia caught in the hospital or from a ventilator. The main goal was to see if the new drug was at least as good at preventing death by day 14. The trial is compl…
Phase: PHASE3 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control
Last updated May 26, 2026 09:30 UTC
-
New pill shows promise for Hard-to-Treat cancers
Disease control CompletedThis study tested an experimental tablet called XNW5004 in 120 adults with advanced tumors or lymphoma that had come back or stopped responding to standard treatments. The main goals were to check the drug's safety and find the best dose. Researchers also looked at how the drug m…
Phase: PHASE1, PHASE2 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control
Last updated May 15, 2026 12:07 UTC